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Business Process Flow Diagrams in Tissue Bank
Informatics System Design, and Identification
and Communication of Best Practices:
The Pharmaceutical Industry Experience
Sandra A. McDonald,1 Elizabeth Velasco,2 and Nicholas T. Ilasi 3

Pfizer, Inc.’s Tissue Bank, in conjunction with Pfizer’s BioBank (biofluid repository), endeavored to create an
overarching internal software package to cover all general functions of both research facilities, including sample
receipt, reconciliation, processing, storage, and ordering. Business process flow diagrams were developed by the
Tissue Bank and Informatics teams as a way of characterizing best practices both within the Bank and in its
interactions with key internal and external stakeholders. Besides serving as a first step for the software development, such formalized process maps greatly assisted the identification and communication of best practices
and the optimization of current procedures. The diagrams shared here could assist other biospecimen research
repositories (both pharmaceutical and other settings) for comparative purposes or as a guide to successful
informatics design. Therefore, it is recommended that biorepositories consider establishing formalized business
process flow diagrams for their laboratories, to address these objectives of communication and strategy.

Introduction

P

fizer, Inc.’s global tissue repository is a collection of
>12,000 human and animal tissue samples obtained
from academic and commercial sources and from a growing
number of clinical trials. Tissues are stored in a variety of
fixed and frozen dispositions to meet various research needs.
The tissues from the bank are used to support a wide variety
of discovery and development programs in the company. On
a volume basis, the majority of bank use is human tissue,
though preclinical species tissues (especially rat, mouse, and
primate) are of increasing importance. The bank assists in the
acquisition, storage, archiving, and supply of tissue through
a centralized inventory and database and offers tissue sectioning, frozen and paraffin-embedded tissue blocks, histologic quality assurance, and scientific consultations on a
request-driven basis to company investigators. Additionally,
the bank is dedicated to the ongoing acquisition of tissues to
meet anticipated research needs. Appropriate consent and
institutional review board approval is in place for all tissues
and contracts, and the use of the tissues is also governed by
Pfizer’s human tissue policy. Pfizer’s tissue repository is
linked (from both informatics and strategic governance
standpoints) with a separate facility (the Pfizer BioBank) for
DNA and biofluids, which has high-capacity, automated

storage capabilities. This biofluids facility can link separate
biofluid and tissue samples when both types are received
from the same patient source.
As part of the globalization and more efficient utilization
of the tissue repository, it was desired to write and implement an overarching internal software package to cover all
general functions of both research biobanking facilities,
including sample receipt, reconciliation, processing, storage,
and ordering. As a first step for that software development,
business process flow diagrams for the Tissue Bank were
prepared through cooperative work between the Bank and
the Research Informatics Division.1 The use of such diagrams
(also referred to as workflow diagrams) to model task-based
laboratories or bioinformatics initiatives, for the purposes of
informatics design or integration, is established in the literature.2,3 Separate flow diagrams had been previously written
for Pfizer’s automated biofluids facility, but because of the
very different laboratory practices of the tissue repository,
new and distinct diagrams were required. In general, multiple advantages were gleaned from this process. The diagrams and associated learning are the subject of this article.
In business process mapping, the main objective was to
focus on business participants that add value (from both
customer and business perspectives), describing what the
participants do from step to step. Sometimes, these maps are
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called business use cases. This is to be distinguished from
system use cases, which automate a business use case, thus
providing detail at the system functionality level, in other
words, what the system does in response to a participant’s
actions. Thus, the advantages of our approach was the creation of fundamental maps that focused on both business
and customer value, and that would provide the foundation
for system use cases and other subsequent work. The main
stakeholders for the work were of 2 broad groups: (1) the
Informatics team who intended to use the diagrams as a
blueprint for further software development, and (2) the Tissue Bank personnel carrying out the business workflow, their
scientific customers, and internal and external tissue sources
that were sometimes contacted as part of the workflows.
The Tissue Bank personnel were the main individuals who
responded to workflow changes and/or changes in best
practices.

Materials and Methods
The Tissue Bank personnel (Laboratory Lead and histotechnologists) met on multiple occasions over a period of
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several weeks (in person and through teleconferences) with
key Research Informatics personnel within Pfizer and closely
examined the existing laboratory practices. The flow diagrams were principally organized along the distinct paths
corresponding to tissue storage dispositions (eg, frozen vs.
fixed tissue and slides vs. blocks) and activity (ordering,
processing, and tissue disbursal), because the inception of
one of these paths was typically the main determinant of
workflow.
For each workflow path, the Tissue Bank personnel first
provided a verbal description of how work was carried out.
The Informatics personnel created a draft of these descriptions using the schemes shown in Figs. 1–5. The Tissue Bank
personnel then reconsidered the processes with the workflow drafts in front of the group, identifying gaps and areas
for refinement. Attention was given to the typical, expected
workflow path and its deviations that were important or
frequent enough to warrant inclusion. Particular attention
was given to the identification of decision points in the
pathways and the points where different pathways intersected or yielded to one another, because these features
would be important for informatics design.

FIG. 1. Business process flow diagram for sample receiving. Single circle at top represents the entry point; double circles at
bottom represent exit points. PI, primary investigator (the person ordering tissues from the bank for research purposes); QC,
quality control; TB, tissue bank; H&E, hematoxylin- and eosin-stained slide, used for QC evaluation of tissues; Lab Lead, the
tissue bank manager and primary strategic decision maker.
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FIG. 2. Business process flow diagram for sample processing, part 1 (paraffin tissue blocks and OCT blocks). Multiple entry
points are present here, including diamond at upper left (‘‘Send paraffin or create slides’’), and the polygons and circles at left and
upper right that start with ‘‘From’’ represent entry points from other flow diagrams. Exit points are the double circle at lower left,
and the circles at right that begin with ‘‘To’’ represent entry to other flow diagrams. OCT, optimal cutting temperature
compound.
The discussions thus continued iteratively until the participants reached a consensus that all key paths and decisions
were captured in the diagrams. The Tissue Bank personnel
reviewed all of their core activities for the prior 3 years to
make sure they had been captured in at least 1 diagram.
After discussions were complete, the diagrams were formalized using the vector graphics capabilities of the Microsoft Office Visio 2007TM program.
The approach here was consistent with the latest version
of the National Cancer Institute’s Best Practices for Biospecimen Repositories, section B.6.4.1,4 which concerns the
development of informatics management systems for biorepositories.

Results
Figures 1–5 show the business process flow diagrams.
These respectively cover (1) sample receipt, including procedures for missing or otherwise problematic samples, (2)
sample processing for paraffinized tissue (both blocks and
histologic slides) and optimal cutting temperature compound (OCT)-embedded tissue, (3) sample processing for
snap-frozen tissue, both that intended to be released as snap-

frozen, unembedded tissue, and that desired to be converted
to an OCT block before release, (4) sample processing for
inventoried glass slides, and (5) handling and approving
sample orders and selecting tissues to fulfill orders. As is
customary with such diagrams, diamond-shaped boxes
indicate decision points, rectangular boxes indicate workflow steps, and circles or polygons show starting points or
endpoints or the places where 1 workflow path joins or leads
to another.

Discussion
The feedback from the Informatics Design team at Pfizer,
Inc., on receipt of the diagrams, was that the diagrams were
quite helpful as a first-step blueprint for the informatics system design covering Pfizer, Inc.’s Tissue Bank and BioBank.
Similarly, for the readership, it is expected that the diagrams
here may serve as a useful guide to biorepository or informatics design or as a comparative guide to best practices. By
examining workflows at the level of depth required to build
the diagrams, best practices can be more readily identified.
Also, areas for improvement and key features required for
a good informatics solution can be identified as well. The
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FIG. 3. Business process
flow diagram for sample processing, part 2 (snap-frozen
tissue). Entry point is the upper diamond (‘‘What is the tissue disposition requested?’’).
Exit points are the double circle
at lower right, and the polygon
at left labeled ‘‘To sample
packing.’’

following discussion highlights the salient points stemming
from the business process flow diagrams.

Identification of separate but interconnected
workflow paths
Different tissue storage dispositions and intended uses
clearly require distinct flow diagram paths. This principle
was important to the success of the project. Probably, the
most fundamental decisions in a research tissue repository
are those between paraffin blocks and frozen tissue, which
meet different research needs, and between snap-frozen and
OCT-embedded tissue, which also address different needs.
However, several areas were identified, where different
paths intersected or yielded to one another. Examples include the need for an OCT block created from a snap-frozen
tissue piece (Fig. 3), yielding to the process flow for OCT
block processing (Fig. 2), and the failure of quality control
(QC) for a slide in the processing pathway (Fig. 3), returning
the user to the search collections pathway in the order flow
diagram (Fig. 5). Another commonly encountered one is the
sectioning of slides from paraffin blocks or OCT blocks (Figs.
2 and 3), which later rejoin the main processing/delivery
pathway for paraffin blocks (also Fig. 2, left). These interconnections were helpful in designing efficient informatics

solutions that would use and return to the basic pathways
when needed, without undue redundancy.
Pathway juxtapositions in the diagrams were also helpful
in the strategic positioning of lab equipment during facility
moves, which took place shortly after the diagrams were
established; for example, a freezer was placed near the
specimen receipt area to accommodate specimens needing
reconciliation or short-term storage (Fig. 1), and frequently
used paraffin blocks and slides were localized close to the
processing areas so they could be readily incorporated into
the workflow (Fig. 5 for sample selection process, followed
by Figs. 2–4 for processing).

Procedures for missing or otherwise
problematic samples
This is a common problem for samples received from
outside sources. The lower half of Fig. 1 shows how this
reconciliation process is handled, subsequent to the process
of receipt covered in the top half of the figure. Note that the
workflow paths for receipt of frozen and fixed samples
eventually unify as they proceed to reconciliation in the
middiagram. The key actions here are the contacts with the
sample source to attempt to resolve the discrepancy and
the incorporation of such information into both the hardcopy
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FIG. 4. Business process flow diagram for
sample processing, part 3 (inventoried slides).
Entry point is the diamond labeled ‘‘Stain
slides?’’ Exit point is the polygon labeled ‘‘To
packing.’’

and electronic rosters. This flow diagram was helpful in the
informatics design and strategic positioning of the reconciliation process, including the electronic rosters and how corrections on them were documented (eg, missing sample and
discrepant sample are handled differently, and the measures
for resolution are distinct within each path).

vendors, and clinical trials. Figure 1 covers these processes as
far as receipt, processing, identification, and discard of frozen samples found to have thawed in transit. Outside samples that satisfy quality assessment criteria can then be
routed through the paths in Fig. 5 (see discussion above)
when it is time to use them for requests.

Inclusion of sample QC decision points in workflow

Customer communication practices

Histologic QC of specimens in the research tissue repository is critically important for assuring that disbursed samples are of the type intended and that they are well preserved
enough to support their intended laboratory use. The pathways incorporate several locations where the quality of
specimens is assessed, including the creation of an OCT
block from a snap-frozen specimen and then the review of a
slide cut from the OCT block (Fig. 3), the review of inventoried slides following their retrieval and, if needed, their
staining (Fig. 4), and review and subsequent choice of the
best specimens to fulfill incoming orders from investigators
(Fig. 5). Identifying the workflow locations where these QC
assessments were being made or used was crucial to the
correct informatics design—in particular, selecting the right
times for these assessments and their entrance into the system, and optimizing the retrieval of QC reviews when they
were needed to help select specimens from the inventory.

Customer communications are a key part of an investigator-focused research tissue repository, and the workflow
paths incorporate several junctures where they are carried
out, both for the purposes of influencing decisions within the
repository (typically regarding specimen selection or processing options) and communicating information of research
benefit to the investigator. As previously mentioned, outside
sources are contacted regarding incoming problematic
specimens (Fig. 1). Note also the customer-centered approach used for delivery of pathology and clinical data
(lower parts of Figs. 2 and 4). Also, note in Fig. 5 that one of
the options at the disposal of the laboratory lead is to contact
the investigator for more information regarding a request,
both before and after an order approval is made. Figure 5
shows how this information is then funneled into an order
approval or rejection or into the path where specimens are
selected from the inventory.

Quality, feasibility, and tracking issues
for specimens from an outside source

Centralized decision making

Although samples can be received from within the company, many samples are obtained from outside sources.
These could include academic collaborations, commercial

The laboratory lead (also known as the tissue bank manager) is the centralized point of order approval and decision
making in these flow diagrams. Recognition of this feature
was crucial in the informatics design, for capture of order
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FIG. 5. Business process
flow diagram for specimen
orders. Entry points are the
double circle at the top, and the
polygon labeled ‘‘From OCT
processing’’ in the middiagram. Exit points are the
thick circles at bottom, and the 2
ovals on the left and right labeled ‘‘Send for processing’’
and ‘‘Cancel sample request,’’
respectively.

approvals and specimen selection, and the correct placement
of these in the software algorithms. Regarding the lead’s
approval options for orders, there are 3 separate but intersecting paths: full approval, partial approval, and order rejection (Fig. 5). As shown in this figure, an interactive
customer-centered approach is important for the latter 2
paths, to resolve the order in a way that is maximally beneficial. One other workflow feature in Fig. 5 is the option to
consider external tissue sources to fulfill an order.

identification and sharing, informatics development, and
stakeholder communications. Using modern software, the
diagrams can be readily updated to reflect changing needs or
business practices. Therefore, research biorepositories should
consider establishing these flow diagrams for their own
settings. Although described here in a pharmaceutical industrial setting, the diagrams would be useful for repositories in other types of institutions also.

Acknowledgments
Conclusion
In conclusion, optimized business process flow diagrams
contribute to the success of several endeavors in pharmaceutical research tissue banking, including best practice

The authors acknowledge the support of Pfizer, Inc., Drug
Safety Research & Development (DSRD) Division, St. Louis
and Groton Laboratories, the sites where the work and
principles described here were developed and practiced.

BUSINESS PROCESS FLOW DIAGRAMS FOR TISSUE BANKING

Author Disclosure Statement
No competing financial interests exist.

209

4. National Cancer Institute (NCI). Best Practices for Biospecimen Repositories, 2010 Revised Version. Office of Biorepositories and Biospecimen Research, National Institutes of Health, U.S. Department of
Health and Human Services. http://biospecimens.cancer.gov.

References
1. McDonald SA, Ilasi N, Velasco E. Identification of best practices in
a pharmaceutical research tissue bank: business process flow
diagrams. ISBER Annual Meeting (HSR #3), Portland, OR, May
12–14, 2009.
2. Goodman N, Rozen S, Stein LD. The LabFlow system for workflow management in large scale biology research laboratories.
Proc Int Conf Intell Syst Mol Biol 1998;6:69–77.
3. Tiwari A, Sekhar AK. Workflow based framework for life science
informatics. Comput Biol Chem 2007;31:305–319.

Address correspondence to:
Dr. Sandra A. McDonald
Department of Pathology and Immunology
Washington University School of Medicine
St. Louis, MO 63110
E-mail: smcdonald@path.wustl.edu
Received 30 August, 2010/Accepted 04 October, 2010

